Gegen Qinlian decoction alleviates experimental colitis via suppressing TLR4/NF-κB signaling and enhancing antioxidant effect

被引:127
作者
Li, Ruiyan [1 ]
Chen, Yingying [1 ,2 ]
Shi, Meijing [1 ]
Xu, Xinxin [1 ]
Zhao, Yaxing [1 ]
Wu, Xiaojun [2 ]
Zhang, Yubin [1 ]
机构
[1] China Pharmaceut Univ, Dept Biochem, State Key Lab Nat Med, Nanjing 210009, Jiangsu, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Shanghai Key Lab Complex Prescript, Inst Chinese Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Gegen Qinlian decoction; UC; TLR4; NF-kappa B; Antioxidant effect; NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; ALPHA PHOSPHORYLATION; TRANSCRIPTION FACTOR; ULCERATIVE-COLITIS; ACTIVATION; THIOREDOXIN; PEROXIDASE; INHIBITION;
D O I
10.1016/j.phymed.2016.06.010
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Background: Gegen Qinlian decoction (GQ), a Chinese medicinal herb decoction, has been widely used as efficient medicine for the treatment of acute colitis in clinics, but underlying molecular mechanisms have not been fully clarified. Hypothesis/purpose: Inflammation and oxidative stress have been reported to constitute a crucial part in the pathogenesis of ulcerative colitis (UC). Hence, this study was designed to investigate the anti-inflammatory activity and antioxidative effect of GQ. Study design: Mice induced by 5% dextran sulfate sodium (DSS) and macrophage RAW264.7 cells stimulated by lipopolysaccharide (LPS) were used in this study. Methods: Ethanol extracts of GQ were orally administered for 1 week on the dosage of 0.3, 1.5, or 7.5 g/kg/day and berberine (BBR, 100 mg/kg/d) was selected as a positive group in the animal experiments. In vitro, GQ (25, 50, 100 mu g/ml) or BBR (20 mu M) co-cultured with RAW264.7 for 2 h prior to LPS stimulation. Results: The results showed that GQ oral administration alleviated the severity of colitis notably. It reduced toll-like receptor 4 (TLR4) expression and NF-kappa B activation in mucosa, which was accompanied with down regulation of several inflammatory cytokines in the colon, including tumor necrosis factor (TNF-alpha), interleukin (IL)-6, IL-1 beta and IL-4. Furthermore, GQ oral administration attenuated the oxidative stress in the colon of UC mice, evidenced by the decrease of myeloperoxidase (MPO) activity and malondialdehyde (MDA) level, and the elevation of glutathione (GSH) content. In parallel with the vivo experiment results, cell research indicated GQ dramatically reduced the production of TNF-alpha, IL-6, IL-1 beta and nitric oxide (NO), as well as that of reactive oxygen species (ROS) upon stimulation of LPS. Conclusion: Together, our present study indicates that inhibition of TLR4/NF-kappa B signaling and enhancement of antioxidant effect might be the potential mechanisms for the therapeutic effect of GQ against UC. (C) 2016 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1012 / 1020
页数:9
相关论文
共 35 条
[1]   TLR signaling in the gut in health and disease [J].
Abreu, MT ;
Fukata, M ;
Arditi, M .
JOURNAL OF IMMUNOLOGY, 2005, 174 (08) :4453-4460
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]   Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS-induced Colitis [J].
Alex, Philip ;
Zachos, Nicholas C. ;
Nguyen, Thuan ;
Gonzales, Liberty ;
Chen, Tian-E ;
Conklin, Laurie S. ;
Centola, Michoel ;
Li, Xuhang .
INFLAMMATORY BOWEL DISEASES, 2009, 15 (03) :341-352
[4]   Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].
Baumgart, Daniel C. ;
Sandborn, William J. .
LANCET, 2007, 369 (9573) :1641-1657
[5]   DEPLETED MUCOSAL ANTIOXIDANT DEFENSES IN INFLAMMATORY BOWEL-DISEASE [J].
BUFFINTON, GD ;
DOE, WF .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (06) :911-918
[6]   The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation [J].
Cui, Li ;
Feng, Liang ;
Zhang, Zhen Hai ;
Jia, Xiao Bin .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 23 (01) :294-303
[7]   New therapies for inflammatory bowel disease: from the bench to the bedside [J].
Danese, Silvio .
GUT, 2012, 61 (06) :918-932
[8]  
Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
[9]   Regulatory role for a novel human thioredoxin peroxidase in NF-κB activation [J].
Jin, DY ;
Chae, HZ ;
Rhee, SG ;
Jeang, KT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (49) :30952-30961
[10]   Pharmacological Intervention Studies Using Mouse Models of the Inflammatory Bowel Diseases: Translating Preclinical Data into New Drug Therapies [J].
Koboziev, Iurii ;
Karlsson, Fridrik ;
Zhang, Songlin ;
Grisham, Matthew B. .
INFLAMMATORY BOWEL DISEASES, 2011, 17 (05) :1229-1245